Member Info for Reddukeclothing

They’ve provided very clear guidance and on cash. Also even IF they had to raise cash , it’s not going to be hard and it won’t be at this low price.

But that’s not on the cards. They’re covering their compete staff hiring from resources

Yes , this is fantastic “ May grew 28% vs April, and June grew 30% vs May”

Indeed, and it is exceptionally good news. All of a sudden even the moat of the fda process and filings is worth the market cap to a 3rd party.

Certainly expecting a move higher, we were £1.36 at the start of q1 when it was first expected

I've sorted it. Apologies for the lack of proof reading !

Hi guys - ask I hold shares in Halifax and Barclays stock brokers - how do I get a letter or representation to be able to join the meeting? Or how did you show proof of ownership to walbrook? Thanks

Excellent update , you couldn't have a better asymmetric investment imo. Enjoy

Reuters have a pretty good article here:
hxxps://www.reuters.com/markets/commodities/lithium-price-slide-deepens-china-battery-giant-bets-cheaper-inputs-2023-02-28/

Didn't he sell £55m shares at IPo? Used it to buy thg property and then rent it back for £19m per year to the company ?

Ha exactly. Every time I see hype like this, it's PI's that get caught in it when it goes wrong. I mean this already is pretty wrong except for those that sold a lot of shares at the top (mm).
Just stay safe people, rationale positions, whichever you want to take

I mean 63.4 also has a tick on it in the video.
If mm is going private and keeping his shares he has motivation to do it for as low as price as possible.

Thanks Jim. Hopefully need Ceo did the deal. May as well wait on results before any announcement

Same open as Hsbc currently. I feel U.K. banks are impairing to smooth income and avoid scrutiny.

Fantastic NatWest results. Let's see . Barc really underperformed

Hi bill, you may be on the wrong board ? Stx is fda approved. ...
They do have an obligation for a trial in children but this is secondary .

Putting this up to my max exposure for the portfolio risk and leaving to mid year . Not been this excited since Switzerland gave them clearance in 2018 and it gave a nod to us fda thereafter ... ??

They have a history of failing for sure. However that's also an opportunity for return as the shareholder base is so fatigued.
With cash burn , and sales people needed there is a risk. For me it's a clear buy as a speculative play however, given the product is finally proven to be wanted by doctors in the us and sales are arriving - vs the market cap , or any dilution from a fund raise at the future share price - it seems like a nice risk / reward

I understand, I was here at the £1.5 level before leaving in dismay . However these level of growth and proof alongside the partnership and money from the worlds biggest generic is a game changer. This is the share it should have been back when fda came along. Now you can get it for 7p!

This is reading really well to me "US Accrufer® annual sales volume of 25,200 prescriptions – a nearly 12-fold increase from 2,152 prescriptions in 2021, and an increase of 97% in H2:2022, when compared to H1"

Thanks - "'There is no shortage of the element itself, as lithium is almost everywhere on Earth, but the pace of extraction/refinement is slow. '" is what Elon said recently . Does this still suit bhl or is he saying refining needs to be sorted vs exploration

What's so good , help me understand the technical output? I read it as business as normal , normal finds, lots more assays due back - no change to strategy or reserves expected. What's the next catalyst ? It is confined the shallow mine or phase 3 and other mining ?